{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:26:46Z","timestamp":1768876006361,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ahj.2013.08.004","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:37:37Z","timestamp":1381883857000},"page":"953-959.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post\u2013Percutaneous Coronary Intervention (RIVER-PCI) trial"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct01442038","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Giora","family":"Weisz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Farzaneh-Far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"DeBruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehtisham","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen P.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Olmsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennyne A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.08.004_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"Serruys","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.004_bb0010","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1001508","article-title":"Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery","volume":"364","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.004_bb0015","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.004_bb0020","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.111.069237","article-title":"Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial","volume":"125","author":"Rosner","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.08.004_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-5223(19)39327-4","article-title":"Long-term results following coronary bypass operation. Importance of preoperative actors and complete revascularization","volume":"82","author":"Buda","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2013.08.004_bb0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jtcvs.2004.12.034","article-title":"In the current era, complete revascularization improves survival after coronary artery bypass surgery","volume":"129","author":"Kleisli","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2013.08.004_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0735-1097(01)01785-5","article-title":"The effect of completeness of revascularization on event-free survival at one year in the ARTS trial","volume":"39","author":"van den Brand","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0040","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/CIRCULATIONAHA.106.612267","article-title":"Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era","volume":"113","author":"Hannan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.08.004_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcin.2008.08.021","article-title":"Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes","volume":"2","author":"Hannan","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcin.2010.01.011","article-title":"Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging","volume":"3","author":"Kirschbaum","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/CIRCINTERVENTIONS.111.963058","article-title":"Impact of incomplete revascularization on long-term mortality after coronary stenting","volume":"4","author":"Wu","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0060","first-page":"102","article-title":"Percutaneous coronary interventions in diabetic patients: is complete revascularization important?","volume":"16","author":"Nikolsky","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ahj.2004.10.037","article-title":"Association between completeness of percutaneous coronary revascularization and postprocedure outcomes","volume":"150","author":"McLellan","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ahj.2006.10.033","article-title":"Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention","volume":"153","author":"Kalarus","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0075","first-page":"448","article-title":"Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents","volume":"72","author":"Tamburino","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCOUTCOMES.108.830091","article-title":"Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial","volume":"2","author":"Mancini","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2013.08.004_bb0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1540-8183.2011.00666.x","article-title":"Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease","volume":"24","author":"Meliga","year":"2011","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0090","first-page":"540","article-title":"The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators","volume":"78","author":"Hussain","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0095","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1161\/CIRCULATIONAHA.111.084236","article-title":"Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial","volume":"126","author":"Vieira","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.08.004_bb0100","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1253\/circj.CJ-11-1285","article-title":"Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era","volume":"76","author":"Chung","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0735-1097(01)01349-3","article-title":"Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience","volume":"38","author":"Suero","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0110","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0735-1097(03)00312-7","article-title":"Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE)","volume":"41","author":"Olivari","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0115","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehi498","article-title":"Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002","volume":"26","author":"Hoye","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCOUTCOMES.108.825760","article-title":"Quantifying the early health status benefits of successful chronic total occlusion recanalization: results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial","volume":"3","author":"Grantham","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2013.08.004_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jcin.2011.03.021","article-title":"Long-term outcome of percutaneous coronary intervention for chronic total occlusions","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.08.004_bb0135","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jcmg.2012.01.005","article-title":"Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention","volume":"5","author":"McPherson","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2013.08.004_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ejcts\/ezr105","article-title":"Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data","volume":"41","author":"Head","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2013.08.004_bb0145","doi-asserted-by":"crossref","first-page":"B137","DOI":"10.1016\/j.jacc.2012.08.508","article-title":"Relationship between reference vessel diameter and the incidence and impact of incomplete coronary revascularization following PCI in ACS: the ACUITY trial","volume":"60","author":"Rosner","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.yjmcc.2006.08.012","article-title":"Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts","volume":"41","author":"Fraser","year":"2006","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl. 4","key":"10.1016\/j.ahj.2013.08.004_bb0155","first-page":"iv6","article-title":"Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine","volume":"92","author":"Belardinelli","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.08.004_bb0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.08.004_bb0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non\u2013ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.08.004_bb0180","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0185","doi-asserted-by":"crossref","first-page":"B210","DOI":"10.1016\/j.jacc.2012.08.759","article-title":"Effects of ranolazine in patients with ACS and stable angina according to whether they undergo PCI: observations from MERLIN-TIMI 36 trial","volume":"60","author":"Scirica","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0190","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","article-title":"Monitoring the quality of life in patients with coronary artery disease","volume":"74","author":"Spertus","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.08.004_bb0195","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-8703(03)00436-8","article-title":"Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease","volume":"146","author":"Mozaffarian","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0200","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/oxfordjournals.eurheartj.a015260","article-title":"Measuring functional status of chronic coronary patients. Reliability, validity and responsiveness to clinical change of the reduced version of the Duke Activity Status Index (DASI)","volume":"18","author":"Alonso","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.08.004_bb0205","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2013.08.004_bb0210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJM197703312961304","article-title":"Foundations of cost-effectiveness analysis for health and medical practices","volume":"296","author":"Weinstein","year":"1977","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:50:34Z","timestamp":1757569834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313005280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0002870313005280"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.08.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post\u2013Percutaneous Coronary Intervention (RIVER-PCI) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}